Cardiac Monitoring and Cardiac Rhythm Management Device Market Research Report –Forecast to 2030

Global Cardiac Monitoring and Cardiac Rhythm Management Device Market, by Cardiac Device (Pacemaker and Others), by Cardiac Monitoring (Electrocardiogram), by CRM (Defibrillators and Others), by End-User (Hospitals and Others)–Global Forecast Till 2030

ID: MRFR/MED/4871-HCR | December 2022 | Region: Global | 85 Pages         

Global Cardiac Monitoring and Cardiac Rhythm Management Device Market

Cardiac monitoring and cardiac rhythm management device market is expected to grow at USD 31.2 billion at a CAGR 6.2% by 2030.

Segmentation

By Cardiac Device Pacemaker and Others
By Cardiac Monitoring Electrocardiogram
By CRM Defibrillators and Others
By End-User Hospitals and Others

Key Players

  • Abiomed
  • Berlin Hearth
  • Brotionik SE and Co. KG
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • General Electric(GE)
  • Hill Rom Services Inc
  • Koninklijke Philips N.V
  • LivaNova plc
  • Medtronic plc

Drivers

  • increasing cardiac disorders
  • changing lifestyle
  • technological advancements in cardiac devices
  • awareness regarding cardiac disorders
Speak to Analyst Request a Free Sample

Cardiac Monitoring and Cardiac Rhythm Management Device Market Overview
 
Cardiac monitoring and cardiac rhythm management device market is expected to grow USD 31.2 billion during the forecast period (2022 to 2030) at a CAGR 6.2%. The cardiac monitoring equipment aids in the observation of the patient's cardiac activity, while the cardiac rhythm management device assists patients with irregular heart rates and rhythm disorders maintain a normal cardiac rhythm. Heart failure, atrial fibrillation, atrial flutter, an indication of a recent heart attack, lack of oxygen delivery to cardiac muscle, and some genetic defects are among the major cardiac illnesses treated using these devices. Increased cardiac illnesses, changing lifestyles, technological improvements in cardiac devices, knowledge of cardiac disorders, healthcare programs, and an increase in the number of unmet medical requirements in both developed and developing countries have all contributed to the market's expansion. During the forecast period, however, the development of novel MRI-labeled devices and the growth of the Asia-Pacific economy are expected to drive the cardiac monitoring device market.
 
Family history, ethnicity, and age are all important risk factors for Cardiac Monitoring and Cardiac Rhythm Management Device Market. The use of tobacco, high blood pressure (hypertension), high cholesterol, obesity, physical inactivity, diabetes, poor diets, and alcohol use are all risk factors. There has been an increase in the incidence of diseases such as hypertension, diabetes, dyslipidemia, and obesity as a result of lifestyle changes, all of which contribute to the rising incidence of Cardiac Monitoring and Cardiac Rhythm Management devices around the world.

Segmentation


The global cardiac monitoring and cardiac rhythm management device market is segmented into types of cardiac devices, types of cardiac monitoring devices, types of cardiac rhythm management devices, and end-users. Further, the types of cardiac devices are segmented into pacemaker, biventricular pacemaker, implantable cardioverter defibrillator, and implantable cardiac loop recorder. Based on the types of cardiac monitoring devices the market is further segmented into electrocardiogram (ECG), Holter monitor, event monitor, implantable loop recorder, and cardiac output monitoring devices. Electrocardiogram (ECG) is further sub-segmented into telelectro-cardiogram, wireless ECG, and lead ECG test. Based on types of cardiac rhythm management devices, the market is segmented into defibrillators, pacemakers, and cardiac resynchronization therapy devices. Defibrillations are further sub-segmented into implantable defibrillators and external defibrillators. Based on end-user the market is segmented into hospitals, ambulatory surgical centers, and others.


Regional Market Summary


Global Cardiac Monitoring and Cardiac Rhythm Management Device Market Share, by Region, 2018 (%)


Cardiac Monitoring and Cardiac Rhythm Management Device Market


Source: MRFR Analysis


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The cardiac monitoring and cardiac rhythm management device market in the Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada. The European cardiac monitoring and cardiac rhythm management device market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The cardiac monitoring and cardiac rhythm management device market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The cardiac monitoring device market in the Middle East and Africa has been segmented into the Middle East and Africa.


In terms of market value, North America will dominate the global cardiac monitoring and cardiac rhythm management device market during the forecast period. The increasing investment by North America in cardiac devices over the last few years has led to the growth of the market in this region. Increasing number of cardiac patients, better healthcare infrastructure, and advanced technology in cardiac monitoring equipment have boosted the cardiac monitoring and cardiac rhythm management device market in North America. The European market is expected to be the second-largest cardiac monitoring device market. The market growth in this region can be attributed to government funding and support of the healthcare sector coupled with increasing research and development. Moreover, a growing number of surgeries due to the changing lifestyle is contributing to the growth of the market in this region. Asia-Pacific is expected to be the fastest-growing cardiac monitoring device market during the forecast period owing to the increasing prevalence of cardiac diseases, rising investments in healthcare, increasing geriatric population, and expansions by market players in the region. Asia-Pacific is giving strong competition in the global cardiac monitoring device market by producing cost-effective products that are high in demand in local as well as global markets. The market in the Middle East and Africa is expected to account for the smallest share in the global cardiac monitoring device market due to the underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global cardiac monitoring and cardiac rhythm management device market are Abiomed, Berlin Hearth, Brotionik SE and Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, General Electric(GE), Hill Rom Services Inc, Jarvik Hearth. Inc, Koninklijke Philips N.V, LivaNova plc, Medtronic plc, Nihon Kohden Corporation, ReliantHeart Inc, Schiller, and Abbott.


Cardiac Monitoring and Cardiac Rhythm Management Device Market, by Types of Cardiac Devices



  • Pacemaker

  • Biventricular Pacemaker

  • Implantable Cardioverter Defibrillator

  • Implantable Cardiac Loop Recorder


Cardiac Monitoring and Cardiac Rhythm Management Device Market, by Types of Cardiac Monitoring Devices



  • Electrocardiogram (ECG)

  • Telelectro-Cardiogram

  • Wireless ECG

  • Lead ECG Test

  • Holter Monitor

  • Event Monitor

  • Implantable Loop Recorder

  • Cardiac Output Monitoring Device


Cardiac Monitoring and Cardiac Rhythm Management Device Market, by Types of Cardiac Rhythm Management (CRM) Devices



  • Defibrillators

  • Implantable Defibrillators

  • External Defibrillators

  • Pacemakers

  • Cardiac Resynchronization Therapy Devices


Cardiac Monitoring and Cardiac Rhythm Management Device Market, by End-User



  • Hospital

  • Home/Ambulator

  • Others


Cardiac Monitoring and Cardiac Rhythm Management Device Market, by Region


Americas



  • North America

  • US

  • Canada

  • South America


Europe



  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe


Asia-Pacific



  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific


Middle East and Africa



  • Middle East

  • Africa


Recent Development


The MoMe Kardia external cardiac diagnostic monitor from InfoBionic became the sole US distributor for BIOTRONIK in 2018. This has allowed the company to extend its cardiovascular solution portfolio, allowing physicians to provide the finest care as quickly and efficiently as possible.
 
Nihon Kohden created a sales branch in Kenya in 2017. This approach has aided the company's ability to maintain a solid consumer base across the Middle East and Africa.
 
Gallant, an implantable cardioverter-defibrillator (ICD), will be available in Europe in 2020, according to Abbott Laboratories.

Intended Audience



  • Government and Academic Institutes

  • Research Laboratories

  • Diagnostic Centers and Research Institutes

  • Cardiac Monitoring and Cardiac Rhythm Management Device Manufacturers

  • Healthcare Providers

  • Medical Device Manufacturers

  • Research Institutes and Academic Centers

  • Contract Research Organizations (CROs)

  • Government Associations

  • Market Research and Consulting



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 31.2 billion: 2030
  CAGR   6.2% :2022-2030
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   by Types, by End-User
  Geographies Covered    North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abiomed, Berlin Hearth, Brotionik SE and Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, General Electric(GE), Hill Rom Services Inc, Jarvik Hearth. Inc, Koninklijke Philips N.V, LivaNova plc, Medtronic plc, Nihon Kohden Corporation, ReliantHeart Inc, Schiller, and Abbott.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers   Increased cardiac illnesses increase in the number of unmet medical


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The Cardiac Monitoring and Cardiac Rhythm Management Device Market can expand at 6.2% CAGR by 2030.

Abiomed, Berlin Hearth, Brotionik SE and Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, General Electric(GE), Hill Rom Services Inc, Jarvik Hearth. Inc, Koninklijke Philips N.V, LivaNova plc, Medtronic plc, Nihon Kohden Corporation, ReliantHeart Inc, Schiller, and Abbott.

North America region is expected to be highly lucrative for the global Cardiac Monitoring and Cardiac Rhythm Management Device Market